Role of the Mosaic Cisternal Maturation Machinery in Glycan Synthesis and Oncogenesis

Tumorigenesis is associated with the deregulation of multiple processes, among which the glycosylation of lipids and proteins is one of the most extensively affected. However, in most cases, it remains unclear whether aberrant glycosylation is a cause, a link in the pathogenetic chain, or a mere consequence of tumorigenesis. In other cases, instead, studies have shown that aberrant glycans can promote oncogenesis. To comprehend how aberrant glycans are generated it is necessary to clarify the underlying mechanisms of glycan synthesis at the Golgi apparatus, which are still poorly understood. Important factors that determine the glycosylation potential of the Golgi apparatus are the levels and intra-Golgi localization of the glycosylation enzymes. These factors are regulated by the process of cisternal maturation which transports the cargoes through the Golgi apparatus while retaining the glycosylation enzymes in the organelle. This mechanism has till now been considered a single, house-keeping and constitutive function. Instead, we here propose that it is a mosaic of pathways, each controlling specific set of functionally related glycosylation enzymes. This changes the conception of cisternal maturation from a constitutive to a highly regulated function. In this new light, we discuss potential new groups oncogenes among the cisternal maturation machinery that can contribute to aberrant glycosylation observed in cancer cells. Further, we also discuss the prospects of novel anticancer treatments targeting the intra-Golgi trafficking process, particularly the cisternal maturation mechanism, to control/inhibit the production of pro-tumorigenic glycans.

DFT and MD simulation supplemented experiments for isotopic fractionation of zinc compounds using a macrocyclic crown ether appended polymeric resin

Isotope effect is a quantum mechanical phenomenon and thus poses a challenge for the separation of isotopes of an element of interest, especially for heavy elements. Isotopic fractionation of zinc is also quite difficult and challenging but is necessitated due to various applications of its isotopes ranging from nuclear medicine to nuclear power reactors. Here, we developed the dibenzo-18-crown-6 (DB18C6) ether-functionalized poly(methacrylic acid) (PMA) resin by exploiting the ion and isotope recognition ability of the crown ether using DFT/MD simulations followed by experiments for isotopic fractionation of zinc. The PMADB18C6 adsorbent was prepared and suitably characterized. Both computational and experimental findings demonstrate that the adsorption and isotope separation of zinc with PMADB18C6 are due to the molecular recognition effect of the "O" dipole of the crown ether. Furthermore, both MD simulations and experiments suggest Langmuir type adsorption isotherms. The adsorption of Zn2+ ions on the PMA resin is predicted to be endothermic, whereas it is exothermic on the PMADB18C6 resin, as revealed from the experimentally observed enthalpy change. A small scale fixed bed column study was demonstrated to test the scale-up application. The values of the experimental separation factors: 1.0013 for 66/64 and 1.0027 for 68/64 confirm the computationally predicted results of 1.00088 and 1.0010, respectively, thus establishing the combined strength of the theory and experiments for the identification of efficient fractionating agents for a complex quantum isotope effect which eventually helps in planning further experiments in view of medicinal and technological applications of zinc isotopes.

Effect of add-on ramelteon therapy on sleep and circadian rhythm disruption in patients with schizophrenia: A randomized controlled trial

The sleep and circadian rhythm disruptions in schizophrenia are attributed to a decrease in nocturnal melatonin level which may worsen if treated with conventional sedative drugs. This study was planned to evaluate the effects of add-on ramelteon on sleep and circadian rhythm disturbances in schizophrenia. A randomized, rater-blinded clinical trial was conducted on 120 patients with schizophrenia. Patients were categorized into predominantly positive (PG) or negative (NG) symptoms depending on Positive and Negative Syndrome Scale (PANSS) scoring, and then they were randomized into control (haloperidol/risperidone) or test (add-on ramelteon) groups. After recruitment, baseline serum melatonin, serum AANAT, urinary melatonin and Pittsburgh Sleep Quality Index (PSQI) were evaluated. Patients were reassessed after 4 weeks of therapy with antipsychotics with or without ramelteon. A significantly greater increase in night-time melatonin level (PG: 10·19; 95%CI: 1·42 to 18·97; p = 0·024; NG: 18·74; 95%CI: 8·48 to 29·0; p = 0·001), decrease in PSQI scores (PG: -1·57; 95%CI: -2·59 to -0·55; p = 0·003; NG: -2·49; 95%CI: -4·59 to -0·39; p = 0·021), increase in urinary melatonin (PG: 0·20; 95% CI: 0·056 to 0·35; p = 0·008; NG :0·15; 95% CI: 0·01 to 0·29; p = 0·034), increase in serum AANAT (PG: 4·61; 95%CI: 1·34 to 7·87; p = 0·007; NG:3·46; 95%CI: 1·30 to 5·63; p = 0·002) and improvement in PANSS score were found in patients receiving add-on ramelteon. The increase in serum melatonin and decrease in PSQI score were greater with predominantly negative symptom group in comparison to positive symptom group. Ramelteon may be considered as an add-on therapy with antipsychotic drugs for sleep and circadian rhythm disturbances in schizophrenia.

Effect of lurasidone vs olanzapine on neurotrophic biomarkers in unmedicated schizophrenia: A randomized controlled trial

Neurotrophic factors like Brain-Derived Neurotrophic Factor (BDNF), Neurotrophin 3 (NT3) and Nerve Growth Factor (NGF), play a role in neuroplasticity and neurogenesis contributing to the pathogenesis of schizophrenia. The objective of the present study was to investigate and compare the effect of olanzapine and lurasidone on the change in serum neurotrophins in patients with schizophrenia. The present study was a randomized, open-label, active-controlled, parallel design clinical trial. After randomization baseline evaluations of serum BDNF, NGF, NT3, Positive and Negative Syndrome Scale (PANSS) scoring, Social and Occupational Functioning Assessment Scale (SOFAS) scoring of 101 unmedicated schizophrenia patients were done. Patients were reassessed after 6 weeks of monotherapy with olanzapine or lurasidone. Serum BDNF increased after treatment with both the drug groups but rise with olanzapine was found to be significantly higher (916.22; 95 %CI: 866.07 to 966.37; p < 0.001) in comparison to lurasidone. Increase in levels NGF and NT3 was also observed but there was no significant difference between the groups (NGF: 2.32; CI: 3.54 to -3.53; p = 0.57 and NT3: 0.99; CI: 2.11 to 0.14; p = 0.086). The difference in improvement in PANSS and SOFASS with both the drugs was not statistically significant. Both the drugs alleviate the symptoms of schizophrenia but olanzapine was better tolerated. Our findings suggest that increase in serum BDNF with olanzapine monotherapy is significantly higher than that with lurasidone but there is no significant difference in change in serum NGF and NT3. TRIAL REGISTRATION: ClinicalTrials.gov identifier: (NCT03304457).

Efficacy of generic oral directly acting agents in patients with hepatitis C virus infection

Novel direct-acting antivirals (DAAs) are now the standard of care for the management of hepatitis C virus (HCV) infection. Branded DAAs are associated with high sustained virological response at 12 weeks post-completion of therapy (SVR12), but are costly. We aimed to assess the efficacy of generic oral DAAs in a real-life clinical scenario. Consecutive patients with known HCV infection who were treated with generic-oral DAA regimens (May 2015 to January 2017) were included. Demographic details, prior therapy and SVR12 were documented. Four hundred and ninety patients (mean age: 38.9 ± 12.7 years) were treated with generic DAAs in the study time period. Their clinical presentations included chronic hepatitis (CHC) in 339 (69.2%) of cases, compensated cirrhosis in 120 (24.48%) cases and decompensated cirrhosis in 31 (6.32%) cases. Genotype 3 was most common (n = 372, 75.9%) followed by genotype 1 (n = 97, 19.8%). Treatment naïve and treatment-experienced (defined as having previous treatment with peginterferon and ribavirin) were 432 (88.2%) and 58 (11.8%), respectively. Generic DAA treatment regimens included sofosbuvir in combination with ribavirin (n = 175), daclatasvir alone (n = 149), ribavirin and peginterferon (n = 80), ledipasvir alone (n = 43), daclatasvir and ribavirin (n = 37), and ledipasvir and ribavirin (n = 6). Overall SVR12 was 95.9% (470/490) for all treatment regimens. SVR12 for treatment naïve and experienced patients was 97.0% (419/432) and 87.9% (51/58), respectively, P = .005. High SVR12 was observed with various regimens, irrespective of genotype and underlying liver disease status. There were no differences in SVR12 with 12 or 24 weeks therapy. No major adverse event occurred requiring treatment stoppage. Generic oral DAAs are associated with high SVR rates in patients with HCV infection in a real-life clinical scenario.

Occult Hepatitis B virus Infection (OBI) predominated by genotype D among chronic liver disease patients: The first report from Odisha, Eastern India

Detection of Occult hepatitis B infection (OBI) has higher significance for treatment and management. There is no information available about the OBI and its genotype associated with chronic hepatitis patients in Odisha, India. We aimed to determine the association of OBI and its genotype among the chronic hepatitis patients in Odisha. In a hospital based study, 175 serum samples of chronic hepatitis patients were screened for Hepatitis surface antigen (HBsAg). All the HBsAg - negative samples were tested for hepatitis B core antibodies (HBcAb). HBcAb-positive samples were tested further for Hepatitis surface antibodies (HBsAb), hepatitis B virus HBV-DNA and HBV genotyping. Of the 89 HBsAg negative samples, 79 (88.8%) were found positive for HBcAb and these patients were presumed to have OBI. Among the total HBcAb positive samples, 22 (27.8%) were positive and 57 (72.2%) were negative for HBsAb. Detection of HBV- DNA from 45 out of 79 HBcAb positive samples (57.0%) yielded positive results for OBI which was negative for HBsAb. Genotyping of all hepatitis B virus showed that all 45 (100%) were genotype-D. Detection of OBI among chronic hepatitis patients suggests testing for OBI for management and treatment.

Beneficiation of limestone plant rejects for value addition

Investigations were carried out on lime stone rejects (-1mm) generated at a lime stone washing plant in southern India. These rejects contain 12.09% CaO, 2.95% MgO, 10.73% Al2O3, 4.99% Fe2O3, 43.05% SiO2 and 24.92% LOI. Mineralogical studies including SEM-EDAX, XRD, FTIR and TGA were conducted to confirm relative distribution of minerals in the flotation feed and products. These studies revealed that feed sample consists of quartz and calcite as the major minerals with minor amounts of montmorillonite and dolomite whereas flotation concentrate dominantly consists of calcite, and tailings mostly of quartz and montmorillonite. A commercial grade sodium silicate, oleic acid and MIBC were used as depressant, collector and frother respectively in flotation studies. The effects of different operating parameters were evaluated for both conventional and column flotation. Two stage conventional cell flotation results indicate that a cleaner concentrate of 42.50% lime (CaO) content could be obtained at a yield of 15.65%. The lime (CaO) content of the concentrate was further enhanced up to 44.23% at 20.73% yield using single stage column flotation. The column flotation is more efficient in comparison to the conventional cell for treating this sample. A process flowsheet was developed to treat these rejects based on the studies carried out. This process can minimize the waste generation and the concentrate generated during this process can be directly utilized in the Indian cement industries.

Metaplastic carcinoma of the breast with high grade spindle cell component with osteoid formation--a rare case report

Metaplastic carcinoma breast is rare entity with incidence of 0.02% of all breast malignancies. The ranges of age at diagnosis as well as clinical symptoms do not differ from that of conventional invasive ductal breast cancer. We are reporting a rare case diagnosed as metaplastic breast carcinoma on ultrasonography and confirmed histopathologically. The case merits presentation because of its rarity, low frequency of axillary metastasis and difficulty in interpreting the morphological features which correspond with prognosis.

Quantum nature of a nuclear phase transition

At finite temperatures and low densities, nuclei may undergo a phase change similar to a classical liquid-gas phase transition. Temperature is the control parameter while density and pressure are the conjugate variables. In the nucleus the difference between the proton and neutron concentrations acts as an additional order parameter, for which the symmetry potential is the conjugate variable. We present experimental results which reveal the N/Z dependence of the phase transition and discuss possible implications of these observations in terms of the Landau free energy description of critical phenomena.

Structure and microstructure evolution during martensitic transformation in wrought Fe–26Mn–0.14C austenitic steel: an effect of cooling rate

Structure and microstructure evolution under various cooling rates of a wrought austenitic steel, Fe–26Mn–0.14C (composition in mass %), were studied by the Rietveld method of X-ray diffraction pattern fitting, grain boundary characterization by electron back-scattered diffraction (EBSD) and optical microscopy. Cooling rate, density of stacking faults, and austenite grain size and grain boundaries influence the observed γfcc→ ∊hcptransformation and lead to significant anisotropic X-ray line broadening. Depending on the cooling conditions, the grain boundaries are misoriented at both lower and higher angles. In the ∊-martensites, the dominant planar fault is twins (∼10−3). The austenite grains were found to contain low to moderate density of stacking faults (∼10−4–10−3), which act as efficient nucleation sites of the ∊-martensites. Both X-ray and EBSD analyses estimated negligible twins in the austenite. Approximate average dislocation densities have been estimated and correlated with the grain structure.

Bainite and stress-induced martensite in an AISI type 300 steel: an X-ray diffraction study of the microstructure by the Rietveld method

The present study concerns the X-ray characterization of the microstructure of an AISI type 300 stainless steel with composition Fe–17Cr–8Ni–1Mn–0.1C (wt%), undergoing stress-induced martensite and bainite transformations following γ(f.c.c.) → α(b.c.c.) transformation reactions. The methodology applied is a Rietveld whole X-ray profile fitting technique, adopting the recently developed softwareMAUD(Materials Analysis Using Diffraction) which incorporates the Popa model for crystallite size and microstrain [root mean square (r.m.s.) strain] and the preferred orientation of the crystallites. The analysis also considers the lattice-defect-related features of the evolved microstructures, namely stacking-fault probabilities and dislocation-density values. The study revealed a high degree of stress-induced martensitic transformation (∼94%) in the cold-worked (hand-filed powder) state of the material. However, no low-temperature martensitic transformation could be observed in this class of materials at temperatures below the martensite start temperature (Ms). On isothermal aging at 673 K for different periods of time (1, 3 and 6 h), the austenite transforms partially into bainite with continuously varying volume fractions (17, 42 and 44%) and the corresponding microhardness values are 218, 230 and 233 kg mm−2. The size–strain–shape analysis adopting the Popa model reveals anisotropic and almost isotropic values of the crystallite sizes and r.m.s. strains in the austenite and bainite microstructures, respectively. High values of the dislocation density (∼1016 m−2) were observed in the bainite due to the plastic deformation of the austenite induced by the shape change of the growing bainite. The values of all the above defect parameters have been evaluated and compared in order to elucidate the structure–property relationships.

Effect of selenium deficiency on hepatic type I 5-iodothyronine deiodinase activity and hepatic thyroid hormone levels in the rat

Selenium deficiency in rats for a period of up to 6 weeks inhibited both the production of 3,3',5-tri-iodothyronine (T3) from thyroxine (T4) (5'-deiodination) and also the catabolism of T3 to 3,3'-di-iodothyronine (5-deiodination) in liver homogenates. The hepatic stores of T3 were decreased by only 8% in selenium deficiency, despite the T3 production rate from T4 being only 7% of the rate found in selenium-supplemented rats. Hepatic glutathione S-transferase (GST) activity was increased in both hypothyroidism and selenium deficiency, but apparently by different mechanisms, since mRNA expression for this family of enzymes was lowered by hypothyroidism and increased in selenium deficiency. It is concluded that, since both T3 production and catabolism are inhibited by selenium deficiency, there is little change in hepatic T3 stores, and therefore the changes in the activity of certain hepatic enzymes, such as GST, that are found in selenium deficiency are not the result of tissue hypothyroidism.